The CD56– ALP– PDGFRa+ population, also referred to as FAPs, showed very limited myogenic capacity based on IF staining for MYOD and MyHC, after a 6-day myotube differentiation, for TD children and patients with CP (Figure 5A). The gene discussed is NCAM1; the disease is thanatophoric dysplasia.